Chemotherapy for primary mediastinal yolk sac tumor in a patient undergoing chronic hemodialysis: a case report

BACKGROUND: The safety and efficacy of chemotherapy for patients undergoing concomitant hemodialysis have not been fully established and optimal doses of anti-cancer drugs and best timing of hemodialysis remains unclear. Although chemosensitive cancers, such as germ cell tumors, treated with chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirakawa, Haruki, Nakashima, Chiho, Nakamura, Tomomi, Masuda, Masanori, Funakoshi, Taro, Nakagawa, Shunsaku, Horimatsu, Takahiro, Matsubara, Kazuo, Muto, Manabu, Kimura, Shinya, Sueoka-Aragane, Naoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312436/
https://www.ncbi.nlm.nih.gov/pubmed/28202048
http://dx.doi.org/10.1186/s13256-017-1213-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312436/
https://www.ncbi.nlm.nih.gov/pubmed/28202048
http://dx.doi.org/10.1186/s13256-017-1213-7

Ejemplares similares